Medtronic to pay $85 million to settle Infuse lawsuit

(Reuters) - Medtronic Inc said it agreed to pay $85 million to settle a shareholder lawsuit accusing it of making misleading statements concerning Infuse, a genetically engineered bone graft used in spinal surgery.

radon engineering remote application monitoring british business gas